Dolutegravir and rilpivirine for the maintenance treatment of virologically suppressed HIV-1 infection

Expert Review of Clinical Pharmacology
Jose L CasadoMiguel A Rodriguez-Sagrado

Abstract

Triple combinations of antiretroviral (ART) drugs are the standard treatment for HIV infection, but the challenges include long-term side effects, high costs, and adherence. The recent advent of potent and well tolerated ART has renewed the interest for newer ART strategies. A dual regimen with the combination of dolutegravir (DTG) and rilpivirine (RPV), two well tolerated, metabolic-friendly, and potent drugs could offer additional benefits. Areas covered: A review of recent randomized trials and observational cohorts concerning the use of a dual therapy with DTG plus RPV as a switching strategy in patients with viral suppression. Expert commentary: Currently, data of more of 900 patients switched to this dual regimen are available. This combination shows a high rate of virological suppression, above 90% at 48 weeks, few discontinuations due to adverse events, improvement in bone and kidney parameters for patients discontinuing tenofovir disoproxil fumarate (TDF), lack of loss of the inflammatory control achieved with triple therapy, and a neutral effect on lipid parameters. Thus, for the first time, a dual regimen without protease inhibitors is effective, avoiding metabolic side effects and drug interactions. Longer follow-up...Continue Reading

References

Nov 4, 2009·Antimicrobial Agents and Chemotherapy·Sherene MinStephen C Piscitelli
Dec 1, 2010·Antimicrobial Agents and Chemotherapy·Masanori KobayashiTamio Fujiwara
Mar 27, 2013·Nature Reviews. Endocrinology·Roger Bedimo, Pablo Tebas
Aug 22, 2013·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Asa M MargolisAndrew Stolbach
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·Susan L FordStephen Piscitelli
Nov 8, 2013·The New England Journal of Medicine·Sharon L WalmsleyUNKNOWN SINGLE Investigators
Dec 19, 2013·Pharmacotherapy·Bhavik M ShahJoseph A Desimone
Feb 19, 2014·The Journal of Antimicrobial Chemotherapy·Christine KatlamaUNKNOWN ROCnRAL ANRS 157 Study Group
May 16, 2014·Current Opinion in HIV and AIDS·Dominique Costagliola
Oct 28, 2014·Expert Opinion on Drug Safety·Susana W Keeshin, Judith Feinberg
Apr 11, 2015·Enfermedades infecciosas y microbiología clínica·Esteban Ribera, Daniel Podzamczer
May 7, 2015·HIV Medicine·J C YombiF A Post
Nov 5, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julia L MarcusMichael J Silverberg
Mar 30, 2016·The Journal of Antimicrobial Chemotherapy·Jhon RojasEsteban Martinez
Mar 30, 2016·Current Opinion in Virology·Tomas Cihlar, Marshall Fordyce
Nov 2, 2016·Antimicrobial Agents and Chemotherapy·Manel AouriUNKNOWN Swiss HIV Cohort Study
Jan 17, 2017·AIDS Research and Human Retroviruses·Leonardo CalzaPierluigi Viale
May 30, 2017·Seminars in Diagnostic Pathology·Emma Kaplan-LewisMikyung Lee
Jun 6, 2017·Enfermedades infecciosas y microbiología clínica·UNKNOWN AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan

❮ Previous
Next ❯

Citations

May 6, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily P HyleRochelle P Walensky
Jun 5, 2020·Enfermedades infecciosas y microbiología clínica·Cecilia TortajadaJuan Flores

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.